Skip to main content
TIL Ltd. logo

TIL Ltd. — Investor Relations & Filings

Ticker · TIL ISIN · INE806C01018 LEI · 254900VU24KB4ODXPY69 BSE.NS Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS TIL

About TIL Ltd.

https://www.tilindia.in/

TIL Ltd. specializes in the design, manufacture, and marketing of a comprehensive range of material handling, lifting, and port equipment. The company’s product portfolio includes mobile cranes, reach stackers, and container handling solutions, as well as equipment for crushing and screening applications. These products are engineered to support large-scale operations in sectors such as infrastructure, mining, and logistics. Through strategic technology alliances with global partners, the company integrates advanced engineering and design capabilities into its manufacturing processes. TIL operates specialized production facilities and maintains an extensive service network to provide technical support, maintenance, and genuine spare parts. The organization focuses on delivering robust, high-performance machinery tailored for complex industrial requirements and heavy-duty applications.

Recent filings

Filing Released Lang Actions
TIL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve letter attached
Regulatory Filings Classification · 85% confidence The document is a notice of a Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements), informing the stock exchanges of the date and agenda items (approval of audited financial results, call money raise, record date). It is an announcement of an upcoming board meeting and does not itself contain financial statements or voting results, nor is it a management change or dividend notice. This type of listing compliance announcement falls under general regulatory filings (RNS).
2026-05-20 English
Letter attached
Capital/Financing Update Classification · 87% confidence The document is a regulatory compliance filing under SEBI Listing Regulations (Regulation 32) providing a statement on the deviation or variation in utilization of proceeds from a recent equity fundraising (convertible warrants). It is a post-fundraising update on capital utilization rather than an earnings, audit, or board change announcement. This fits the Capital/Financing Update category (CAP).
2026-05-02 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding a statement on deviation or variation of funds under SEBI Listing Regulations. It references a previous letter and provides a revised statement confirming no deviation or variation in the utilization of proceeds from equity shares allotted pursuant to convertible warrants. The document includes a detailed table outlining the mode of fund raising, amount raised, and utilization of funds. The content focuses on compliance with regulatory disclosure requirements about fund utilization rather than presenting financial results, management discussion, or audit opinions. The document length is 3475 characters, which is relatively short and primarily serves as a regulatory compliance update. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement related to fund utilization and compliance, not a full financial report or earnings release.
2026-05-02 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a statement on deviation or variation of funds under Regulation 32 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It reports on the utilization of proceeds from equity shares allotted pursuant to conversion of warrants, specifically for the quarter and financial year ended 31st March 2026. The content is a compliance disclosure about fund usage with no deviation, including details of the original and utilized funds. It is not a full financial report, audit report, or earnings release, but a regulatory compliance filing related to capital raising and fund utilization. The document length is 3261 characters, relatively short and focused on regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like Capital/Financing Update (CAP) or Annual Report (10-K).
2026-04-30 English
Letter attached
Regulatory Filings
2026-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.